The Journal of infectious diseases · 2026
Assessing the Effect of Malaria Exposure History on Tetanus Antibody Waning Rates Among Children in Jinja and Tororo Districts, Uganda.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sbarra Alyssa N, Stone Will, Tetteh Kevin, Ssewanyana Isaac, Musinguzi Kenneth, Rodríguez-Barraquer Isabel, Jagannathan Prasanna, Bach Florian A, Drakeley Chris, Takahashi Saki
Аннотация
BACKGROUND: Malaria causes immune perturbations and affects immunogenicity to vaccines. It is unknown, however, how repeated malaria infections affect the duration of vaccine protection. This study assessed variability in tetanus antitoxin immunoglobulin G (IgG) antibody kinetics including by malaria exposure history at district and individual levels.
METHODS: We analyzed tetanus antitoxin IgG antibody concentrations in 3064 plasma samples from 2011 to 2017 in 597 children aged 6 months to 10 years residing in the Tororo (high malaria transmission) and Jinja (low transmission) districts in Uganda. Mixed-effects models were used to estimate antibody half-lives, and hazard models to estimate the risk of seroreversion.
RESULTS: Tetanus antitoxin IgG antibody concentrations were estimated to fall below protective levels by age 8.1 years [95% confidence interval (CI), 6.4-10.2 years]. Antibody half-lives were significantly longer in Jinja (15.8 [95% CI, 8.8-28.5] years) than in Tororo (2.8 [2.6-3.1] years). Hazard of seroreversion was significantly higher (2.7-fold [1.7-4.1-fold]) in Tororo than in Jinja.
CONCLUSIONS: Tetanus antibodies waned rapidly. Children living in the district with high malaria transmission had faster waning and a higher risk of seroreversion than those in the district with low transmission, suggesting the need to determine if malaria endemicity should inform timing of tetanus booster delivery.
METHODS: We analyzed tetanus antitoxin IgG antibody concentrations in 3064 plasma samples from 2011 to 2017 in 597 children aged 6 months to 10 years residing in the Tororo (high malaria transmission) and Jinja (low transmission) districts in Uganda. Mixed-effects models were used to estimate antibody half-lives, and hazard models to estimate the risk of seroreversion.
RESULTS: Tetanus antitoxin IgG antibody concentrations were estimated to fall below protective levels by age 8.1 years [95% confidence interval (CI), 6.4-10.2 years]. Antibody half-lives were significantly longer in Jinja (15.8 [95% CI, 8.8-28.5] years) than in Tororo (2.8 [2.6-3.1] years). Hazard of seroreversion was significantly higher (2.7-fold [1.7-4.1-fold]) in Tororo than in Jinja.
CONCLUSIONS: Tetanus antibodies waned rapidly. Children living in the district with high malaria transmission had faster waning and a higher risk of seroreversion than those in the district with low transmission, suggesting the need to determine if malaria endemicity should inform timing of tetanus booster delivery.